Entwicklung von Kinderarzneimitteln, Reduzierung von Off-Label-Gebrauch bei Kindern

This procedure addresses the development of medicines for children and the reduction of their off-label use. It aims to improve the availability and appropriate use of medications for pediatric patients. It focuses on ensuring that children receive treatments that are specifically tested and approved for them, thereby enhancing their health outcomes and safety.